Recent drug approvals for acute myeloid leukemia

by Catherine Lai, Kimberley Doucette, Kelly Norsworthy
Published 2019-09-01

A Phase 1 Study of IRX195183, a RARα-Selective CYP26 Resistant Retinoid, in Patients With Relapsed or Refractory AML

by Alexander J. Ambinder, Kelly Norsworthy, Daniela Hernandez, Laura Palau, Bogdan Paun, Amy Duffield, Rosh Chandraratna, Martin Sanders, Ravi Varadhan, Richard J. Jones, B. Douglas Smith, Gabriel Ghiaur
Published 2020-10-01